Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             125 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Aims & Scope/Editorial Board 2011
 1 3-4 p. IFC-
1 p.
 artikel
2 Angiogenin and apoptosis in hypertension in pregnancy Karthikeyan, Vellore J.
 2011
 1 3-4 p. 191-196
6 p.
 artikel
3 Are components of the Renin Angiotensin System (RAS) associated with oxidative stress in normotensive (NT) and pre-eclamptic (PE) placentae? Kurlak, Lesia O.
 2011
 1 3-4 p. 280-
1 p.
 artikel
4 Association of augmentation index with uterine artery Doppler and risk of preeclampsia Everett, Thomas R.
 2011
 1 3-4 p. 290-291
2 p.
 artikel
5 Different effects of different phosphodiesterase type-5 inhibitors in pre-eclampsia Karasu, Edibe
 2011
 1 3-4 p. 231-237
7 p.
 artikel
6 Does a patient information sheet lead to better understanding of pre-eclampsia? A randomised controlled trial van der Merwe, J.L.
 2011
 1 3-4 p. 225-230
6 p.
 artikel
7 Increased maternal growth-differentiation factor-15 in preeclampsia does not predict endothelial function 5–8 years postpartum Sugulle, Meryam
 2011
 1 3-4 p. 294-
1 p.
 artikel
8 Increase of high molecular weight adiponectin in hypertensive pregnancy was correlated with brain-type natriuretic peptide stimulation on adipocyte Naruse, Katsuhiko
 2011
 1 3-4 p. 200-205
6 p.
 artikel
9 Interleukin-18 concentrations in pregnancies complicated by preeclampsia with and without IUGR: A comparison with normotensive pregnant women with isolated IUGR and healthy pregnant women Laskowska, Marzena
 2011
 1 3-4 p. 206-212
7 p.
 artikel
10 ISSHP Author Index 2011
 1 3-4 p. I-III
nvt p.
 artikel
11 L15. Biological aspects of inositol phosphoglycans in human pregnancy and preeclampsia Scioscia, Marco
 2011
 1 3-4 p. 247-248
2 p.
 artikel
12 L28. Calcium antagonists in hypertensive disorders of pregnancy Giannubilo, S.R.
 2011
 1 3-4 p. 254-255
2 p.
 artikel
13 L2. Clinical utility of placental growth factor – Pathological insights from commercial assays Redman, Christopher
 2011
 1 3-4 p. 239-
1 p.
 artikel
14 L20. Differences in the hemodynamic profile between pre-eclampsia and other forms of hypertension in pregnancy Borghi, Claudio
 2011
 1 3-4 p. 250-
1 p.
 artikel
15 L30. Echocardiographic markers of cardiovascular risk after pregnancy complications and cardiovascular outcome after a 4 years follow up Valensise, H.
 2011
 1 3-4 p. 256-
1 p.
 artikel
16 L7. Evaluation of different model for the prediction of late preeclampsia at the 1st trimester of pregnancy Farina, Antonio
 2011
 1 3-4 p. 242-
1 p.
 artikel
17 L8. First trimester screening for pre-eclampsia Khalil, Asma
 2011
 1 3-4 p. 243-
1 p.
 artikel
18 L5. Genetic aspects of preeclampsia Marozio, L.
 2011
 1 3-4 p. 240-241
2 p.
 artikel
19 L22. How we might do without vitamins Facchinetti, F.
 2011
 1 3-4 p. 251-
1 p.
 artikel
20 L14. Hyperglycemia and adverse pregnancy outcome (HAPO) study: Preeclampsia Hod, Moshe
 2011
 1 3-4 p. 246-247
2 p.
 artikel
21 L1. Imitators of severe preeclampsia Sibai, Baha M.
 2011
 1 3-4 p. 238-239
2 p.
 artikel
22 L27. Management of non severe gestational hypertension through the modulation of total vascular resistance Novelli, G.P.
 2011
 1 3-4 p. 254-
1 p.
 artikel
23 L21. Maternal cardiac function in normal and complicated twin pregnancy: A longitudinal study Ghi, Tullio
 2011
 1 3-4 p. 250-251
2 p.
 artikel
24 L19. Maternal cardiac function in preeclampsia Thilaganathan, Basky
 2011
 1 3-4 p. 249-250
2 p.
 artikel
25 L9. NGAL, an early marker of endothelial dysfunction in preeclampsia D’Anna, R.
 2011
 1 3-4 p. 243-
1 p.
 artikel
26 L29. Pathophysiology and treatment of hypertension in women in the different phases of life Leuzzi, C.
 2011
 1 3-4 p. 255-256
2 p.
 artikel
27 L4. Placental inflammatory factors and preeclampsia Voltolini, Chiara
 2011
 1 3-4 p. 240-
1 p.
 artikel
28 L6. Placental oxygenation and respiration in preeclampsia Cetin, Irene
 2011
 1 3-4 p. 241-
1 p.
 artikel
29 L10. Prediction and prevention of preeclampsia in autoimmune disease Mecacci, F.
 2011
 1 3-4 p. 244-
1 p.
 artikel
30 L31. Preeclampsia: Not only a disease of pregnancy Sibai, Baha M.
 2011
 1 3-4 p. 256-257
2 p.
 artikel
31 L25. Renal disease and preeclampsia Manfellotto, Dario
 2011
 1 3-4 p. 252-253
2 p.
 artikel
32 L26. Severe preeclampsia: When to deliver? C, Benedetto
 2011
 1 3-4 p. 253-254
2 p.
 artikel
33 L23. Short and long term neurological consequences of (pre) eclampsia Zeeman, Gerda
 2011
 1 3-4 p. 251-252
2 p.
 artikel
34 L24. The meaning of proteinuria in preeclampsia. Lindheimer, M.D.
 2011
 1 3-4 p. 252-
1 p.
 artikel
35 L17. The role of aldosterone in normal and preeclamptic pregnancies Mohaupt, Markus
 2011
 1 3-4 p. 248-249
2 p.
 artikel
36 L16. The role of glycemic control in the development of preeclampsia in type 1 diabetic women Mello, G.
 2011
 1 3-4 p. 248-
1 p.
 artikel
37 L12. The role of heparin in the prevention of preeclampsia Ferrazzani, S.
 2011
 1 3-4 p. 245-
1 p.
 artikel
38 L13. The routine measurement of the sFlt1/PlGF ratio allows differential diagnosis of hypertensive pregnancy disorders and has prognostic potential in preeclamptic patients Verlohren, Stefan
 2011
 1 3-4 p. 245-246
2 p.
 artikel
39 L18. Total Vascular Resistance in complicated pregnancies Vasapollo, B.
 2011
 1 3-4 p. 249-
1 p.
 artikel
40 L3. Trophoblast invasion and spiral artery transformation in pre-eclampsia and fetal growth restriction Lyall, Fiona
 2011
 1 3-4 p. 239-240
2 p.
 artikel
41 L11. Using biochemical markers of cardiac function to predict preeclampsia Cecchi, Stefano
 2011
 1 3-4 p. 244-245
2 p.
 artikel
42 O10. An obesity-related FTO variant and the risk of pre-eclampsia in a Finnish study population Klemetti, M.
 2011
 1 3-4 p. 261-262
2 p.
 artikel
43 O20. Body liquids sectors of puerperal women with preeclampsia and their diagnostic role Jonboboeva, G.N.
 2011
 1 3-4 p. 266-
1 p.
 artikel
44 O28. Cardiovascular biomarkers during and after preeclamptic pregnancy Sugulle, Meryam
 2011
 1 3-4 p. 271-272
2 p.
 artikel
45 O8. Comparison of two placental growth factor immunoassays as an aid in the diagnosis of preterm preeclampsia Myers, J.E.
 2011
 1 3-4 p. 260-261
2 p.
 artikel
46 O26. Decreased vision-related quality of life following eclampsia Wiegman, M.J.
 2011
 1 3-4 p. 270-271
2 p.
 artikel
47 O1. Dramatic upregulation of HIF-1α in the endovascular and extravillous trophoblasts at the maternal-fetal interface in preeclamptic pregnancies Hwang, JongYun
 2011
 1 3-4 p. 257-
1 p.
 artikel
48 O23. Effects of S-nitrosoglutathione (GSNO) on arterial stiffness in severe early-onset preeclampsia Everett, Thomas R.
 2011
 1 3-4 p. 268-269
2 p.
 artikel
49 O18. Endothelial function and glucose metabolism in overweight and obese nondiabetic woman: A possible role of l-Arginine/Nitric Oxide pathway Petrella, Elisabetta
 2011
 1 3-4 p. 265-
1 p.
 artikel
50 O9. Evaluating fetal cord blood lipids and oxidized LDL status in intrauterine growth restriction and preeclampsia Pecks, U.
 2011
 1 3-4 p. 261-
1 p.
 artikel
51 O17. Hypertension in pregnancy and endothelial dysfunction: An emerging risk factor for cardiovascular disease Gagliardi, G.
 2011
 1 3-4 p. 265-
1 p.
 artikel
52 O27. Hypertensive disorders in pregnancy and risk of severe mental disorders in the offspring in adulthood: The Helsinki Birth Cohort study Tuovinen, Soile
 2011
 1 3-4 p. 271-
1 p.
 artikel
53 O14. Impaired mid-gestational maternal cardiac function and left ventricular remodelling in women who subsequently develop preterm but not term preeclampsia Melchiorre, K.
 2011
 1 3-4 p. 263-264
2 p.
 artikel
54 O24. Is there any cardiovascular effect of carbetocin utilization that might prevent its use in preeclampsia? A TVR and CO study Pisani, I.
 2011
 1 3-4 p. 269-270
2 p.
 artikel
55 O19. Kidney transplantation and pregnancy: Maternal and fetal outcome Ferreira, A.
 2011
 1 3-4 p. 265-266
2 p.
 artikel
56 O5. Low-dose aspirin therapy in pregnant women with chronic hypertension Baptista, E.
 2011
 1 3-4 p. 259-
1 p.
 artikel
57 O13. Microvascular and macrovascular hemodynamic effects of nicardipine in the treatment of severe pre-eclampsia Cornette, J.
 2011
 1 3-4 p. 263-
1 p.
 artikel
58 O11. Myo-inositol may prevent metabolic and hypertensive disorders in PCOS pregnant women D’Anna, R.
 2011
 1 3-4 p. 262-
1 p.
 artikel
59 O15. Non-invasive assessment of hemodynamics in early pregnancy van der Graaf, Anne Marijn
 2011
 1 3-4 p. 264-
1 p.
 artikel
60 O16. Placental folate receptor alpha (FR-α) and proton coupled folate transporter (PCFT) mRNA and protein expression are decreased in pre-eclampsia Williams, P.
 2011
 1 3-4 p. 264-265
2 p.
 artikel
61 O4. Predisposing factors for early- and late-onset preclampsia Ornaghi, S.
 2011
 1 3-4 p. 259-
1 p.
 artikel
62 O25. Preeclampsia is associated to persistent long-term postpartum left ventricular myocardial injury Melchiorre, K.
 2011
 1 3-4 p. 270-
1 p.
 artikel
63 O12. Pre-pregnancy to early pregnancy changes in maternal cardiovascular physiology Mahendru, Amita A.
 2011
 1 3-4 p. 262-263
2 p.
 artikel
64 O7. Prospective evaluation of ultrasound and biochemical-based multivariable models for the prediction of late preeclampsia Farina, Antonio
 2011
 1 3-4 p. 260-
1 p.
 artikel
65 O22. Secondary preventive interventions of cardiovascular risk in women who had hypertension during pregnancy after 36 weeks gestation Kesteren, F.v.
 2011
 1 3-4 p. 267-268
2 p.
 artikel
66 O2. Serum concentrations of angiogenic factors as predictors of severity of preeclampsia, in Colombian population Páez, M.C.
 2011
 1 3-4 p. 258-
1 p.
 artikel
67 O3. The predominante of Th17 lymphocytes and decreased number and function of Treg cells are present in preeclampsia Darmochwal-Kolarz, D.
 2011
 1 3-4 p. 258-
1 p.
 artikel
68 O21. Total vascular resistance and multigate spectral doppler analysis (MSDA) as a screening tool for preeclampsia: A pilot study Tiralongo, G.M.
 2011
 1 3-4 p. 267-
1 p.
 artikel
69 O6. Uterine artery Doppler in a risk population: What’s its role in the prediction of small for gestational age fetuses? Cameroni, Irene
 2011
 1 3-4 p. 260-
1 p.
 artikel
70 P6. Active and inactivated hemopexin in pregnancy and preeclampsia: Do they activate monocytes and endothelial cells? Spaans, F.
 2011
 1 3-4 p. 275-
1 p.
 artikel
71 P52. Age and parity as a risk factor for preeclampsia Aghamohammadi, Azar
 2011
 1 3-4 p. 298-
1 p.
 artikel
72 P13. Alterations in placental expression of Caveolin-1, Cavin-1 and eNOS in women with pre-eclampsia Smith-Jackson, Kate
 2011
 1 3-4 p. 278-279
2 p.
 artikel
73 P30. Angiogenic factors combined with clinical risk factors to predict preterm preeclampsia in nulliparous women Myers, J.E.
 2011
 1 3-4 p. 286-287
2 p.
 artikel
74 P18. Angiogenic factors for the prediction of early- and late onset preeclampsia in a high risk cohort Villa, P.M.
 2011
 1 3-4 p. 282-
1 p.
 artikel
75 P53. Association between trombophilia and preeclampsia Berks, D.
 2011
 1 3-4 p. 298-
1 p.
 artikel
76 P36. Association of aortic stiffness with uterine artery Doppler pulsatility index and risk of preeclampsia Everett, Thomas R.
 2011
 1 3-4 p. 289-
1 p.
 artikel
77 P5. Bioinformatic analysis of protein–protein interaction network in preeclampsia Tejera, E.
 2011
 1 3-4 p. 275-
1 p.
 artikel
78 P48. Brain injury on pregnancy Santi, B. Wicaksono
 2011
 1 3-4 p. 295-296
2 p.
 artikel
79 P8. Circulating ficolins in normal pregnancy and preeclampsia Molvarec, A.
 2011
 1 3-4 p. 276-
1 p.
 artikel
80 P27. Clinical utility of uric acid in the detection of preeclampsia in hypertensive pregnancy – Preliminary results Campos, S.
 2011
 1 3-4 p. 285-
1 p.
 artikel
81 P19. Comparing the pregnancy outcome in nuliparas both with and without microalbuminuria at the end of the second trimester of pregnancy Kashanian, Maryam
 2011
 1 3-4 p. 282-
1 p.
 artikel
82 P39. Comparison of amino terminal pro brain natriuretic peptide levels in hypertensional gestational syndrome and normotensive pregnancy Marcela, Cabo Fustaret
 2011
 1 3-4 p. 290-
1 p.
 artikel
83 P26. Comparison serum inhibin A level, placenta inhibin A level and placenta inhibin A expression in severe preeclampsia/eclampsia and normal pregnant women Arisanti, Y.
 2011
 1 3-4 p. 285-
1 p.
 artikel
84 P32. Did calcium management prevent preeclampsia? Nenad, Sulovic
 2011
 1 3-4 p. 287-
1 p.
 artikel
85 P11. Differentially expressed micro-RNAs in microparticles from haemoglobin perfused placentas Rasmussen, T.
 2011
 1 3-4 p. 277-278
2 p.
 artikel
86 P49. Do circulating angiogenic factors in pregnancies complicated by diabetes mellitus predict angiogenic factors and endothelial function postpartum? Kvehaugen, Anne Stine
 2011
 1 3-4 p. 296-
1 p.
 artikel
87 P22. Evaluation of a new, simple and rapid placental growth factor test for the evaluation of hypertensive disorders in pregnancy Stenczer, Balázs
 2011
 1 3-4 p. 283-
1 p.
 artikel
88 P43. Fathers with PTSD and depression in pregnancies complicated by preeclampsia or PPROM Stramrood, C.A.I.
 2011
 1 3-4 p. 293-
1 p.
 artikel
89 P40. HELLP syndrome – statistic of the department Marques, C.
 2011
 1 3-4 p. 292-
1 p.
 artikel
90 P42. Hypertensive disorders in pregnancy and risk of severe mental disorders in the offspring in adulthood: The Helsinki Birth Cohort Study Tuovinen, S.
 2011
 1 3-4 p. 292-293
2 p.
 artikel
91 P35. Hypertensive disorders in pregnant women affected by type 1 diabetes De Carolis, S.
 2011
 1 3-4 p. 288-289
2 p.
 artikel
92 P45. Improving the quality of care using evidence-based approaches in hypertension in pregnancy: The role of audit to optimisze clinical effectiveness Khodzhaeva, Z.S.
 2011
 1 3-4 p. 294-295
2 p.
 artikel
93 P25. Increased inhibin A in severed preeclampsia/eclampsia Arisanti, Y.
 2011
 1 3-4 p. 284-285
2 p.
 artikel
94 P50. Infant growth following a hypertensived pregnancy Green, A.
 2011
 1 3-4 p. 296-297
2 p.
 artikel
95 P41. Long term objective higher visual functioning and vision-realted quality of life following eclampsia Postma, I.R.
 2011
 1 3-4 p. 292-
1 p.
 artikel
96 P37. Non-invasive haemodynamic monitoring using transthoracic echocardiography in pregnancy: Validation against cardiac catheterisation Cornette, Jerome
 2011
 1 3-4 p. 289-290
2 p.
 artikel
97 P54. Normotensive–hypertensive pregnancy patterns among pregnant women of abstract child bearing ages: A Chinese study Sosorburam,
 2011
 1 3-4 p. 298-299
2 p.
 artikel
98 P3. Placental effects of antihypertensives on activin A and inhibin A in pre-eclampsia Gangooly, S.
 2011
 1 3-4 p. 274-
1 p.
 artikel
99 P10. Placental expression of haemostatic and angiogenic markers in preeclampsia Kelly, Lynne
 2011
 1 3-4 p. 277-
1 p.
 artikel
100 P12. Placental gene expression analysis at the end of the first trimester of pregnancy in patients at high risk of subsequent development of preeclampsia Anderson, Ulrik Dolberg
 2011
 1 3-4 p. 278-
1 p.
 artikel
101 P23. Prediction of preeclampsia during early pregnancy in primiparas with soluble fms-like tyrosine kinase-1 and placental growth factor Rohra, Dileep Kumar
 2011
 1 3-4 p. 283-284
2 p.
 artikel
102 P20. Prediction of preterm preeclampsia by combining histidine-rich glycoprotein and uterine artery Doppler in early pregnancy Bolin, Marie
 2011
 1 3-4 p. 282-283
2 p.
 artikel
103 P28. Predictive value of the sFlt-1/PlGF ratio in pregnancies at risk for hypertensive disorders Husse, S.
 2011
 1 3-4 p. 285-286
2 p.
 artikel
104 P51. Pregnancy stimulates cerebellar hemangioblastoma growth in von Hippel-Lindau disease Frantzen, C.
 2011
 1 3-4 p. 297-
1 p.
 artikel
105 P34. Prepregnancy body mass index, weight gain and hypertensive disorders in pregnancy Letizia, Cannata M.
 2011
 1 3-4 p. 288-
1 p.
 artikel
106 Pre-pregnancy cardiovascular risk in women with previous preeclampsia (PET)/intrauterine growth restriction (IUGR) Mahendru, Amita A.
 2011
 1 3-4 p. 291-292
2 p.
 artikel
107 P31. Risk factors for Pre-eclampsia, study in Iran Kashanian, Maryam
 2011
 1 3-4 p. 287-
1 p.
 artikel
108 P7. Role of EGF-like domain 7 (Egfl7) in placental development and implantation Salvi, Silvia
 2011
 1 3-4 p. 275-276
2 p.
 artikel
109 P21. Role of uterine artery doppler in pregnant women with chronic hypertension Moita, B.
 2011
 1 3-4 p. 283-
1 p.
 artikel
110 P17. Significance of uteroplacental Doppler at midtrimester in low risk parous women Tiziana, Arcangeli
 2011
 1 3-4 p. 281-
1 p.
 artikel
111 P24. Study of C677T methylene tetrahydrofolate reductase (MTHFR) polymorphism in preeclampsia Matos, Andreia
 2011
 1 3-4 p. 284-
1 p.
 artikel
112 P1. Targeted gene arrays across the severely-discordant growth monochorionic twin placenta: Implications for angiogenesis and metabolic programming Schrey, S.
 2011
 1 3-4 p. 273-
1 p.
 artikel
113 P47. The application of the electrolyte balanced hydroxyethylstarch solution – Tetraspan in complex infusion therapy of preeclampsia in perioperative care Jonboboeva, G.N.
 2011
 1 3-4 p. 295-
1 p.
 artikel
114 P44. The effect of hypertensive disorders in pregnancy on quality of life post partum Brussé, Ingrid A.
 2011
 1 3-4 p. 293-294
2 p.
 artikel
115 P2. The effects of statins and antihypertensives on placental secretion of angiogenic proteins in term pre-eclampsia Gangooly, S.
 2011
 1 3-4 p. 273-274
2 p.
 artikel
116 P9. The elecsys assay for PlGF, sFlt1 and their ratio (sFlt1/PlGF) as an aid in differential diagnosis of pregnancy-related hypertensive disorders Engels, T.
 2011
 1 3-4 p. 276-277
2 p.
 artikel
117 P15. The influence of maternal Lewis, Secretor and ABO(H) blood groups on pre-eclampsia and fetal growth restriction Clark, Peter
 2011
 1 3-4 p. 280-
1 p.
 artikel
118 P14. The number and location of vessels with decidual vasculopathy correlate with disease severity in preeclampsia Stevens, Droïma
 2011
 1 3-4 p. 279-280
2 p.
 artikel
119 P46. TOTEM study (temporise or terminate pregnancy in women with severe preeclampsia at 28–34 weeks): A study protocol Duvekot, J.J.
 2011
 1 3-4 p. 295-
1 p.
 artikel
120 P33. Uterine artery Doppler and biochemical markers (PAPP-A, PlGF, sFlt-1, P-Selectin, NGAL) at 11+0 to 13+6weeks in the prediction of late (>34weeks) preeclampsia Farina, Antonio
 2011
 1 3-4 p. 287-288
2 p.
 artikel
121 P16. Uterine artery Doppler ultrasonography and pre-eclampsia Raposo, S.
 2011
 1 3-4 p. 280-281
2 p.
 artikel
122 P4. Uteroplacental arterio-venosus difference in sFlt, but not in endoglin concentrations in preeclampsia Roland, M.C.P.
 2011
 1 3-4 p. 274-
1 p.
 artikel
123 P29. Vascular reactivity in preeclampsia assessed using finger tip hyperemia in a rural African setting Meeme, A.
 2011
 1 3-4 p. 286-
1 p.
 artikel
124 Selenium and preeclampsia: A global perspective Vanderlelie, J.
 2011
 1 3-4 p. 213-224
12 p.
 artikel
125 Severe pre-eclampsia and HELLP syndrome after massive fetomaternal hemorrhage following blunt abdominal trauma Faber, V.J.
 2011
 1 3-4 p. 197-199
3 p.
 artikel
                             125 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland